Imagine a computer that scans your medical records, lab results, and even your social media, then predicts your risk of heart attack or readmission. That's clinical data analytics, and it's exploding. The US clinical data analytics market report by MRFR shows that patient care is the largest application, but pharmacovigilance (drug safety) is the fastest‑growing. The market is $1.85 billion and will hit $5.04 billion by 2035, growing at 9.54% CAGR. Why the surge? Because healthcare is drowning in data, and analytics is the lifeboat.

What's driving growth? Cloud‑based deployment is the largest, but on‑premises is the fastest‑growing — as hospitals worry about data security. The US clinical data analytics market analysis highlights that healthcare providers are the largest end‑user segment, but pharmaceutical companies are the fastest‑growing — as they use analytics for drug discovery and safety monitoring.

What's new? AI that reads radiology images, predicts sepsis, and even suggests diagnoses. Also, natural language processing (NLP) that extracts data from unstructured clinical notes.

The bottom line: clinical data analytics is not about replacing doctors — it's about giving them superpowers. And it's already saving lives.